Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Rimonabant Treatment on Cardiovascular Risk Factors in Renal Transplant Recipients -- Pilot Safety Study

NCT00525681 is registered in ClinicalTrials.gov with University of Oslo School of Pharmacy as lead sponsor.

NCT NCT00525681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00525681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Rimonabant Treatment on Cardiovascular Risk Factors in Renal Transplant Recipients -- Pilot Safety Study
Lead sponsor
University of Oslo School of Pharmacy
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2007
Completion date
May 31, 2008
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplantation